ViewRay to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
ViewRay, Inc. (NASDAQ: VRAY) has announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference from November 23 to December 3, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ViewRay, Inc. (NASDAQ: VRAY) has announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference from November 23 to December 3, 2020. A fireside chat recording will be available for registered attendees on the conference site, and it will also be posted on the Company's website. On December 1st, ViewRay will hold investor meetings, which must be requested through Piper Sandler. ViewRay specializes in the MRIdian radiation therapy system, focusing on advanced radiation oncology solutions.
Details
News Market Reaction – VRAY
The recorded move for VRAY in the trading session of this news was +0.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Nov. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference.
From November 23 to December 3, 2020, a fireside chat recording will be available for registered attendees via the Piper Sandler conference site. A recording will also be posted to the Company's website at https://investors.viewray.com/events-and-presentations/upcoming-events.
ViewRay will be participating in investor meetings on Tuesday, December 1st, which can be requested exclusively via Piper Sandler.
About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference-301178411.html
SOURCE ViewRay, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.